Gemini Therapeutics GMTX

Quarterly report 2026-Q1
added 05-05-2026

Country	USA
IPO year	-
Industry	-
Stock Exchange	NASDAQ GLOBAL

Shares	35.3 M
Market Cap^[1]	$ 67.4 M
EBITDA (LTM)	$ -166 M
P/E (LTM)	-
P/S (LTM)	-
EPS (LTM)	-6.02

References

Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.